American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.
Fujii DE, Ahmed I. Risk factors in psychosis secondary to traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):61-9.
1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.
2. van Os J, Bak M, Hanssen M, et al. Cannabis use and psychosis: a longitudinal population-based study. Am J. Epidemiol. 2002 Aug 15;156(4):319-27.
3. Arseneault L, Cannon M, Poulton R, et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002 Nov 23;325(7374):1212-3.
4. Smit F, Bolier L, Cuijpers P. Cannabis use and the risk of later schizophrenia: a review. Addiction. 2004 Apr;99(4):425-30.
5. Caussy D, Priest ND. Introduction to arsenic contamination and health risk assessment with special reference to Bangladesh. Rev Environ Contam Toxicol. 2008;197:1-15.
6. Nadkarni S, Arnedo V, Devinsky O. Psychosis in epilepsy patients. Epilepsia. 2007;48 Suppl 9:17-9.
7. Fujii DE, Ahmed I. Risk factors in psychosis secondary to traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):61-9.
8. Reiss JP, Sam D, Sareen J. Psychosis in multiple sclerosis associated with left temporal lobe lesions on serial MRI scans. J Clin Neurosci. 2006 Feb;13(2):282-4.
9. Lisanby SH, Kohler C, Swanson CL, et al. Psychosis secondary to brain tumor. Semin Clin Neuropsychiatry. 1998 Jan;3(1):12-22.
10. Rabins PV, Starkstein SE, Robinson RG. Risk factors for developing atypical (schizophreniform) psychosis following stroke. J Neuropsychiatry Clin Neurosci. 1991 Winter;3(1):6-9.
11. Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006 Mar;163(3):521-8.
12. Pearlman DM, Najjar S. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophr Res. 2014 Aug;157(1-3):249-58.
13. MacQueen GM, Rosebush PI, Mazurek MF. Neuropsychiatric aspects of the adult variant of Tay-Sachs disease. J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):10-9.
14. Muntjewerff JW, Kahn RS, Blom HJ, et al. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry. 2006 Feb;11(2):143-9.
15. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol. 1992 Apr;49(4):401-6.
16. van Rijn S, Aleman A, Swaab H, et al. Klinefelter's syndrome (karyotype 47,XXY) and schizophrenia-spectrum pathology. Br J Psychiatry. 2006 Nov;189:459-60.
17. Mors O, Mortensen PB, Ewald H. No evidence of increased risk for schizophrenia or bipolar affective disorder in persons with aneuploidies of the sex chromosomes. Psychol Med. 2001 Apr;31(3):425-30.
18. National Institute for Health and Care Excellence. Delirium in adults. Quality standard [QS63]. July 2014 [internet publication].
19. Eyer P. Neuropsychopathological changes by organophosphorus compounds - a review. Hum Exp Toxicol. 1995 Nov;14(11):857-64.
20. Aardema H, Meertens JH, Ligtenberg JJ, et al. Organophosphorus pesticide poisoning: cases and developments. Neth J Med. 2008 Apr;66(4):149-53.
21. Ebdrup BH, Lublin H, Akeson P, et al. Patients with first-episode psychosis should not be scanned routinely [in Danish]. Ugeskr Laeger. 2011 Feb 14;173(7):484-9.
22. Moreira-Almeida A, Cardeña E. Differential diagnosis between non-pathological psychotic and spiritual experiences and mental disorders: a contribution from Latin American studies to the ICD-11. Rev Bras Psiquiatr. 2011 May;33 Suppl 1:S21-36.
23. World Health Organization. International statistical classification of diseases and related health problems, 10th revision (ICD-10). Chapter V. Mental and behavioural disorders (F00-F99). 2016 [internet publication].
24. National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. Clinical guideline [CG185]. September 2014 [internet publication].
25. National Institute for Health and Care Excellence. Psychosis and schizophrenia in adults: prevention and management. Clinical guideline [CG178]. March 2014 [internet publication].
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台